E
Sell
2/10/2025Downgrade
Nutex Health Inc. (NUTX) was downgraded to E+ from D- on 2/10/2025 due to a significant decline in the growth index and valuation index. Earnings per share declined from -$0.0733 to -$1.7232, operating cash flow declined 48.8% from $13.26M to $6.79M, and EBIT declined 15.72% from $11.97M to $10.09M.
D
Sell
9/13/2024Upgraded
Nutex Health Inc. (NUTX) was upgraded to D- from E+ on 9/13/2024 due to a significant increase in the growth index, valuation index and solvency index. EBIT increased 725.75% from $1.45M to $11.97M, operating cash flow increased 334.63% from $3.05M to $13.26M, and earnings per share increased from -$0.1 to -$0.0733.
E
Sell
11/22/2022Downgrade
Nutex Health Inc. (NUTX) was downgraded to E+ from D on 11/22/2022 due to a substantial decline in the efficiency index, solvency index and growth index. Net income declined 2,078.4% from -$19.4M to -$422.52M, earnings per share declined from -$0.03 to -$0.6505, and EBIT declined 1,318.32% from $2.51M to -$30.55M.
D
Sell
11/11/2022Upgraded
Nutex Health Inc. (NUTX) was upgraded to D from D- on 11/11/2022 due to an increase in the volatility index and total return index.
D
Sell
10/27/2022Downgrade
Nutex Health Inc. (NUTX) was downgraded to D- from D on 10/27/2022 due to a decline in the volatility index.
D
Sell
10/7/2022Upgraded
Nutex Health Inc. (NUTX) was upgraded to D from D- on 10/7/2022 due to an increase in the valuation index and volatility index.
D
Sell
8/23/2022None
Nutex Health Inc. (NUTX) was downgraded to D- from U on 08/23/2022.
